CD33 and acute myeloid leukemia: This study examined whether CD11b+ CD33+HLA‐DR− MDSC‐like blasts with the same phenotype as MDSC are present in the BM of AML patients and whether these cells exert immunosuppressive functions to promote leukemic cell proliferation.